Title:
ＬＯＸ阻害剤
Document Type and Number:
Japanese Patent JP2022507335
Kind Code:
A
Abstract:
本開示は、式Ｉの化合物又はその薬学的に許容可能な塩に関する。式（Ｉ）は、本明細書に定義される通りある。式Ｉで示される化合物は、リシルオキシダーゼ（ＬＯＸ）阻害剤として薬理学的に有効であり、たとえば、癌の治療に有用であると考えられる。【化１】TIFF2022507335000187.tif27170【選択図】なし
Inventors:
Aljara, Mohammed
Niklesk-Duvac, Dan
Lung, Leo
Smith, Deborah
Brown, michael
Davis, Lawrence Christopher
Springer, Caroline
Niklesk-Duvac, Dan
Lung, Leo
Smith, Deborah
Brown, michael
Davis, Lawrence Christopher
Springer, Caroline
Application Number:
JP2021525843A
Publication Date:
January 18, 2022
Filing Date:
November 15, 2019
Export Citation:
Assignee:
The Institute of Cancer Research: Royal Cancer Hospital
International Classes:
C07D239/42; A61K31/407; A61K31/495; A61K31/498; A61K31/506; A61K31/5377; A61K31/541; A61K31/551; A61P1/16; A61P7/00; A61P9/04; A61P11/00; A61P13/12; A61P17/00; A61P35/00; A61P43/00; C07D243/08; C07D295/104; C07D471/18; C07D487/04; C07D487/08; C07D487/10
Attorney, Agent or Firm:
Mitsuo Matsui
Hiroshi Murakami
Hiroshi Murakami
Previous Patent: Devices and methods for deleting user device capability identification information
Next Patent: How to make a random copolymer
Next Patent: How to make a random copolymer